NCT00283218View on ClinicalTrials.gov

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.

NACompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

August 31, 2006

Conditions

Type 1 Diabetes

Interventions

DRUG

NovoRapid, NovoMix 30, Bifasisk Insulin Aspart 50, BIAsp70

Trial Locations (1)

8000

Dept of Medicine M, Aarhus University Hospital, Nørrebrogade 44, Aarhus

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Novo Nordisk A/S

INDUSTRY

lead

University of Aarhus

OTHER